Shopping Cart
Remove All
Your shopping cart is currently empty
TTX-080 is a human monoclonal antagonistic antibody targeting human leukocyte antigen G (HLA-G). By neutralizing HLA-G mediated immune suppression, TTX-080 exhibits antitumor activity. It holds potential for use in research involving solid tumors such as metastatic colorectal cancer (mCRC) and metastatic head and neck squamous cell carcinoma (mHNSCC).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Backorder | Backorder | |
| 5 mg | Inquiry | Backorder | Backorder |
| Description | TTX-080 is a human monoclonal antagonistic antibody targeting human leukocyte antigen G (HLA-G). By neutralizing HLA-G mediated immune suppression, TTX-080 exhibits antitumor activity. It holds potential for use in research involving solid tumors such as metastatic colorectal cancer (mCRC) and metastatic head and neck squamous cell carcinoma (mHNSCC). |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.